ESMO Clinical Practice Guideline interim update on the use of targeted therapy in acute lymphoblastic leukaemia

Ann Oncol. 2024 Jan;35(1):15-28. doi: 10.1016/j.annonc.2023.09.3112. Epub 2023 Oct 11.
No abstract available

Keywords: ESMO Clinical Practice Guideline update; acute lymphoblastic leukaemia; immunotherapy; treatment; tyrosine kinase inhibitor.

Publication types

  • Practice Guideline

MeSH terms

  • Humans
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy